Epidemic Typhus (Rickettsia prowazekii)
Overview
Plain-Language Overview
Epidemic Typhus is a serious infectious disease caused by the bacterium Rickettsia prowazekii. It primarily affects the blood vessels and causes widespread inflammation throughout the body. The infection is spread by body lice, which transmit the bacteria when they bite humans. Symptoms include high fever, severe headache, and a characteristic rash that starts on the trunk and spreads outward. This disease can lead to complications such as organ failure if not treated promptly. It mainly impacts the skin, blood vessels, and nervous system, causing significant illness.
Clinical Definition
Epidemic Typhus is a systemic infectious disease caused by the obligate intracellular bacterium Rickettsia prowazekii, transmitted by the human body louse. The core pathology involves vasculitis due to bacterial invasion of endothelial cells lining small blood vessels, leading to increased vascular permeability and inflammation. Clinically, it presents with an abrupt onset of high fever, severe headache, myalgias, and a maculopapular rash that typically begins on the trunk and spreads centrifugally. The disease is significant for its potential to cause multiorgan dysfunction and high mortality if untreated. It is historically associated with crowded, unsanitary conditions and outbreaks during wars or famines. Diagnosis and early treatment are critical to reduce morbidity and mortality.
Inciting Event
Bite from infected body louse (Pediculus humanus corporis) introduces Rickettsia prowazekii into the bloodstream.
Louse feces inoculation into skin abrasions during scratching facilitates bacterial entry.
Close contact with infested individuals or contaminated clothing initiates transmission.
Latency Period
Incubation period ranges from 1 to 2 weeks after louse exposure before symptom onset.
Symptoms typically develop 7 to 14 days post-infection, reflecting bacterial replication and endothelial invasion.
Diagnostic Delay
Nonspecific early symptoms such as fever and headache mimic other febrile illnesses, delaying suspicion.
Lack of awareness in non-endemic areas leads to missed or late diagnosis.
Rash onset after fever may be delayed, causing initial misattribution to viral infections.
Limited access to serologic or PCR testing in resource-poor settings impedes timely confirmation.
Clinical Presentation
Signs & Symptoms
Sudden onset high fever with chills and severe headache
Myalgias and malaise are prominent
Rash appears 5-9 days after fever onset, starting on the trunk
Delirium or stupor may occur in severe cases
Photophobia and conjunctivitis are common
History of Present Illness
Abrupt onset of high fever and severe headache marks initial presentation.
Myalgias and malaise develop early and are prominent.
Maculopapular rash appears 3 to 5 days after fever onset, typically starting on the trunk and spreading to extremities but sparing the face, palms, and soles.
Delirium, photophobia, and cough may occur in severe cases.
Prolonged untreated illness can lead to hypotension and multi-organ failure.
Past Medical History
Previous louse infestations or poor hygiene conditions increase risk of recurrent exposure.
History of living in or traveling to endemic areas is relevant.
No specific chronic diseases alter susceptibility but immunocompromised states may worsen prognosis.
Family History
No known heritable predisposition or familial syndromes associated with epidemic typhus.
Clusters of cases may occur in families due to shared environmental exposure to lice.
Physical Exam Findings
Maculopapular rash beginning on the trunk and spreading centrifugally to the extremities, sparing the face, palms, and soles
Fever often high and abrupt in onset
Tachycardia disproportionate to fever
Lymphadenopathy may be present
Conjunctival injection without purulent discharge
Diagnostic Workup
Diagnostic Criteria
Diagnosis of epidemic typhus is based on a combination of clinical presentation including fever, headache, and characteristic rash, along with a history of exposure to body lice. Laboratory confirmation is achieved by serologic testing demonstrating a fourfold rise in antibody titers against Rickettsia prowazekii or by PCR detection of bacterial DNA. Skin biopsy of the rash showing vasculitis with rickettsial organisms on immunohistochemistry can support diagnosis. Early recognition of the clinical syndrome in the appropriate epidemiologic context is essential for prompt diagnosis.
Pathophysiology
Key Mechanisms
Endothelial cell infection by Rickettsia prowazekii leads to vasculitis and increased vascular permeability.
Immune-mediated inflammation causes widespread microvascular damage and tissue hypoxia.
Release of endotoxins triggers systemic inflammatory response contributing to fever and rash.
Louse-borne transmission facilitates rapid spread in crowded conditions, enhancing pathogen dissemination.
| Involvement | Details |
|---|---|
| Organs | Skin manifests the characteristic maculopapular rash due to endothelial injury and inflammation. |
Brain may be affected in severe cases causing encephalitis and neurological symptoms. | |
Lungs can develop interstitial pneumonitis secondary to vascular injury. | |
| Tissues | Vascular endothelium is critically involved as the site of bacterial invasion causing widespread vasculitis and rash. |
| Cells | Endothelial cells are the primary target of Rickettsia prowazekii, leading to vasculitis and increased vascular permeability. |
Macrophages participate in the immune response by phagocytosing infected cells and releasing cytokines. | |
| Chemical Mediators | Tumor necrosis factor-alpha (TNF-α) is elevated and contributes to systemic inflammation and endothelial damage. |
Interleukin-1 (IL-1) promotes fever and inflammatory responses during infection. |
Treatments
Pharmacological Treatments
Doxycycline
- Mechanism:
Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit of Rickettsia prowazekii.
- Side effects:
Photosensitivity
Gastrointestinal upset
Tooth discoloration in children
- Clinical role:
First-line
Chloramphenicol
- Mechanism:
Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, effective against Rickettsia prowazekii.
- Side effects:
Aplastic anemia
Gray baby syndrome
Bone marrow suppression
- Clinical role:
Second-line
Non-pharmacological Treatments
Maintain strict hygiene and delousing measures to control the body louse vector.
Provide supportive care including hydration and fever management.
Prevention
Pharmacological Prevention
Doxycycline prophylaxis in high-risk populations during outbreaks
Use of chloramphenicol as an alternative in doxycycline-allergic patients
Non-pharmacological Prevention
Louse control through improved personal hygiene and insecticide use
Avoidance of overcrowding and improved sanitation to reduce louse transmission
Screening and treatment of lice infestations in endemic areas
Outcome & Complications
Complications
Pneumonia due to secondary bacterial infection or direct lung involvement
Myocarditis leading to heart failure
Neurologic complications including encephalitis and seizures
Shock from severe systemic inflammation
Death if untreated, especially in elderly or immunocompromised patients
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Epidemic Typhus (Rickettsia prowazekii) versus Murine Typhus (Rickettsia typhi)
Epidemic Typhus (Rickettsia prowazekii) | Murine Typhus (Rickettsia typhi) |
|---|---|
Exposure to body lice in crowded, unhygienic conditions | Exposure to fleas from rodents in urban or suburban areas |
Rash often involves the trunk and spreads centrifugally, sometimes involving palms and soles | Rash typically spares the palms and soles |
More severe systemic illness with potential for encephalitis and myocarditis | Usually milder illness with fewer severe complications |
Epidemic Typhus (Rickettsia prowazekii) versus Rocky Mountain Spotted Fever (Rickettsia rickettsii)
Epidemic Typhus (Rickettsia prowazekii) | Rocky Mountain Spotted Fever (Rickettsia rickettsii) |
|---|---|
Body louse exposure in epidemic settings with poor hygiene | Tick bite exposure in endemic areas such as southeastern and south-central US |
Rash starts on trunk and spreads centrifugally | Rash begins on wrists and ankles and spreads centrally |
High mortality in untreated epidemic typhus, especially in malnourished or elderly | Higher mortality if untreated, especially in children |
Epidemic Typhus (Rickettsia prowazekii) versus Typhoid Fever (Salmonella Typhi)
Epidemic Typhus (Rickettsia prowazekii) | Typhoid Fever (Salmonella Typhi) |
|---|---|
Transmission via body lice in epidemic outbreaks | Ingestion of contaminated food or water in endemic areas |
Maculopapular rash more widespread, often involving trunk and extremities | Rose spots are few, blanching, and mainly on the trunk |
Serology or PCR positive for Rickettsia prowazekii | Positive blood culture for Salmonella Typhi |
Epidemic Typhus (Rickettsia prowazekii) versus Infectious Mononucleosis (Epstein-Barr Virus)
Epidemic Typhus (Rickettsia prowazekii) | Infectious Mononucleosis (Epstein-Barr Virus) |
|---|---|
Mild leukopenia or normal white count without atypical lymphocytes | Marked lymphocytosis with atypical lymphocytes |
High fever, severe headache, and rash without prominent pharyngitis | Prominent pharyngitis, tonsillar exudates, and cervical lymphadenopathy |
Positive serology or PCR for Rickettsia prowazekii | Positive heterophile antibody (Monospot) test |
Epidemic Typhus (Rickettsia prowazekii) versus Secondary Syphilis (Treponema pallidum)
Epidemic Typhus (Rickettsia prowazekii) | Secondary Syphilis (Treponema pallidum) |
|---|---|
Maculopapular rash often involving trunk and extremities, may involve palms and soles | Symmetric, copper-colored, nonpruritic rash involving palms and soles |
Exposure to body lice in epidemic conditions | Sexual contact with infected partner |
Positive serology or PCR for Rickettsia prowazekii | Positive non-treponemal and treponemal serologic tests |